Results 41 to 50 of about 31,421 (293)

Increased incidence and risk of septicemia and urinary tract infection after Clostridioides difficile infection [PDF]

open access: yes, 2023
BACKGROUND: Although increased occurrence of septicemia in persons with METHODS: The first episode of CDI was identified using 2011-2017 MarketScan and CMS Medicare data and CDI cases categorized by standard surveillance definitions.
Dubberke, Erik R   +4 more
core   +2 more sources

Novel Drivers of Virulence in Clostridioides difficile Identified via Context-Specific Metabolic Network Analysis

open access: yesmSystems, 2021
Clostridioides difficileC ...
Matthew L. Jenior   +8 more
doaj   +1 more source

High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates [PDF]

open access: yes, 2019
Clostridium [Clostridioides] difficile infection (CDI) is one of the leading causes of diarrhea associated with medical care worldwide, and up to 60% of patients with CDI can develop a recurrent infection (R-CDI). A multi-species microbiota biofilm model
Baines, Simon   +9 more
core   +1 more source

Update on commonly used molecular typing methods for Clostridioides Difficile [PDF]

open access: yes, 2023
This review aims to provide a comprehensive overview of the significant Clostridioides difficile molecular typing techniques currently employed in research and medical communities.
Abad-Fau, Ana   +4 more
core   +1 more source

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection

open access: yesGut Pathogens, 2021
Background Clostridioides difficile infection (CDI) is an infectious nosocomial disease caused by Clostridioides difficile, an opportunistic pathogen that occurs in the intestine after extensive antibiotic regimens. Results Nine C.
Seung Woo Ahn   +7 more
doaj   +1 more source

Clostridioides Difficile Enteritis: Case Report and Literature Review

open access: yesAntibiotics, 2022
Background: Clostridioides Difficile is a well-known pathogen causing diarrhea of various degrees of severity through associated infectious colitis.
Artsiom Klimko   +6 more
doaj   +1 more source

Rare Clinical Association between Clostridioides difficile Infection and Ischemic Colitis: Case Report and Literature Review

open access: yesMedicina, 2021
Background and Objectives: Gut microbiota plays an important role in the wellbeing of the host through different interactions between microflora constituents. In certain instances, Clostridioides difficile may pullulate, causing infection with associated
Elena Mirela Ionescu   +6 more
doaj   +1 more source

Anaerobic 4-hydroxyproline utilization: Discovery of a new glycyl radical enzyme in the human gut microbiome uncovers a widespread microbial metabolic activity. [PDF]

open access: yes, 2018
The discovery of enzymes responsible for previously unappreciated microbial metabolic pathways furthers our understanding of host-microbe and microbe-microbe interactions. We recently identified and characterized a new gut microbial glycyl radical enzyme
Balskus, Emily P   +2 more
core   +1 more source

Molecular epidemiology and antimicrobial resistance of Clostridioides difficile in Germany, 2014–2019

open access: yesInternational Journal of Medical Microbiology, 2021
Clostridioides difficile is a Gram positive spore-forming rod and mainly responsible for nosocomial diarrhea in developed nations. Molecular and antimicrobial surveillance is important for monitoring the strain composition including genotypes of high ...
Ahmed Mohamed Mostafa Abdrabou   +9 more
doaj  

Sentinel surveillance and epidemiology of Clostridioides difficile in Denmark, 2016 to 2019 [PDF]

open access: yes, 2022
BACKGROUND: Since 2008, Danish national surveillance of Clostridioides difficile has focused on binary toxin-positive strains in order to monitor epidemic types such as PCR ribotype (RT) 027 and 078.
Andersen, Leif Percival   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy